EC approves CSL and Arcturus Therapeutics’ KOSTAIVE mRNA COVID-19 vaccine
The European Commission (EC) has officially granted COVID-19 vaccine approval for KOSTAIVE, the first self-amplifying mRNA vaccine for COVID-19, developed by CSL and Arcturus Therapeutics. ... Read More
CSL Behring bags Hemgenix EC approval for treatment of Hemophilia B
German-based biotechnology company CSL Behring has received conditional marketing authorization (CMA) from the European Commission (EC) for its Hemgenix (etranacogene dezaparvovec) indicated for the treatment ... Read More